Showing results (181-190 of 213) with videos related to

Sort By:
Pageof 22
Atherosclerosis|October 1, 1982
High density lipoprotein subfractions in insulin-dependent diabetic and normal subjectsM B Mattock, A M Salter, J H Fuller, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 2000
A locus influencing total serum cholesterol on chromosome 19p: results from an autosomal genomic scan of serum lipid concentrations in Pima IndiansG Imperatore, W C Knowler, D J Pettitt, et al.
Diabetologia|July 16, 2008
Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications StudyJ W J Beulens, J S Kruidhof, D E Grobbee, et al.
Diabetes Care|February 24, 2001
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications StudyM A Crook, J C Pickup, P J Lumb, et al.
Diabetes|September 3, 1998
Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDMG Penno, N Chaturvedi, P J Talmud, et al.
Diabetologia|January 25, 2006
All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999S S Soedamah-Muthu, J H Fuller, H E Mulnier, et al.
Diabetologia|October 16, 2002
Trends in hypertension management in Type I diabetes across Europe, 1989/1990 - 1997/1999S S Soedamah-Muthu, H M Colhoun, H Abrahamian, et al.
British Medical Journal|October 20, 1979
Haemostatic variables associated with diabetes and its complicationsJ H Fuller, H Keen, R J Jarrett, et al.
Diabetologia|April 18, 2000
Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications StudyB Karamanos, M Porta, M Songini, et al.
Lancet (London, England)|January 20, 1998
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes MellitusN Chaturvedi, A K Sjolie, J M Stephenson, et al.
Pageof 22